Siemens Healthcare Diagnostics Recalls Atellica CH Urine Albumin Test Kits Due to Inaccurate Results
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Siemens Healthcare Diagnostics is recalling Atellica CH Urine Albumin kits because they may provide falsely low results for patients with high albumin concentrations.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 2, 2026 and geographically references Worldwide. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-device.
What Happened
Siemens Healthcare Diagnostics, Inc. has initiated a voluntary recall of its Atellica CH Urine Albumin (UAlb) diagnostic test kits. The recall was issued because the product may produce falsely depressed patient results. According to the FDA, samples with a urine albumin concentration above the measuring interval (>40.0 mg/dL) may incorrectly report values between 6.2 mg/dL and 40.0 mg/dL.
Which Products Are Affected
The recall involves approximately 4,885 units distributed worldwide, including across the United States. The following product details identify the affected items:
- Product Name: Atellica CH Urine Albumin (UAlb)
- Material Number: 11537225
- UDI-DI: 00630414611099
- Lot Numbers: All lot numbers are included in this recall.
What You Should Do
Siemens Healthcare Diagnostics notified customers of this issue via a formal letter. Laboratories and healthcare facilities using the Atellica CH Urine Albumin kits should follow the instructions provided in the firm's notification. This typically includes identifying affected inventory and assessing the need for potential re-testing of patient samples that may have been impacted by the reporting error.
Why This Matters
Inaccurate medical test results can lead to incorrect clinical assessments and delayed treatment for patients. Falsely low albumin readings may mask underlying medical conditions that require intervention.
Source
This information is based on official recall data from the FDA under recall number Z-1484-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.